Target intelligence / Profile preview

RNA, variant U1 small nuclear 6 (RNVU1-6)

Target
RNVU1-6
Molecular classification
Small nuclear RNA, Non-coding RNA, snRNA family
01

Overview

RNA, variant U1 small nuclear 6 (RNVU1-6) is a member of the variant U1 small nuclear RNA gene family, part of the large repertoire of snRNA genes that form core components of the major spliceosome, which is the complex responsible for precursor mRNA splicing in eukaryotic cells. RNVU1-6, like other U1 snRNAs, is predicted to bind to the 5'-splice site of pre-mRNA, facilitating the recognition and joining of exons during splicing. It is predicted to be located in the nucleus and is a part of the U1 small nuclear ribonucleoprotein particle (U1 snRNP). The exact individual function of RNVU1-6 compared to canonical U1 snRNAs is not fully characterized, but variant U1 snRNAs share high sequence homology and conserved promoter elements, indicating probable functional potential. There is no direct evidence supporting therapeutic targeting or roles in pathology for this specific variant, and no known drugs interact with it. Fundamental research has shown mutations in the broader U1 snRNA locus can contribute to disease, mostly through effects on splicing fidelity, but there are no reports of clinical biomarkers, targeted therapies, or safety concerns linked to RNVU1-6 itself.

Other names
vU1.6RNU1-99RNVU1-6
02

Biological functions

Pre-mRNA 5'-splice site bindingmRNA 5'-splice site recognitionSpliceosome componentRegulation of gene expression (splicing)
03

Disease associations

Other (non-coding SNV variants in U1 snRNA loci are recurrently found in certain cancers; no direct evidence for RNVU1-6 specifically)

Beyond the preview

Go deeper on RNA, variant U1 small nuclear 6 (RNVU1-6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, variant U1 small nuclear 6 (RNVU1-6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call